Showing results (1-10 of 96) with videos related to
Sort By:
Pageof 10
Journal of Clinical Hypertension (Greenwich, Conn.)|August 9, 2006
Nitric oxide mechanisms in the pathogenesis of global riskR Preston MasonCurrent Drug Targets. Cardiovascular & Haematological Disorders|March 1, 2006
A rationale for combined therapy with a calcium channel blocker and a statin: evaluation of basic and clinical evidenceR Preston MasonCurrent Atherosclerosis Reports|January 15, 2019
New Insights into Mechanisms of Action for Omega-3 Fatty Acids in Atherothrombotic Cardiovascular DiseaseR Preston MasonVascular Health and Risk Management|July 29, 2011
Optimal therapeutic strategy for treating patients with hypertension and atherosclerosis: focus on olmesartan medoxomilR Preston MasonCerebrovascular Diseases (Basel, Switzerland)|May 13, 2003
Atheroprotective effects of long-acting dihydropyridine-type calcium channel blockers: evidence from clinical trials and basic scientific researchR Preston MasonAtherosclerosis|November 6, 2002
Mechanisms of plaque stabilization for the dihydropyridine calcium channel blocker amlodipine: review of the evidenceR Preston MasonThe American Journal of Medicine|December 17, 2005
A rationale for combination therapy in risk factor management: a mechanistic perspectiveR Preston MasonCurrent Hypertension Reports|May 22, 2012
Pleiotropic effects of calcium channel blockersR Preston MasonThe American Journal of Cardiology|November 28, 2006
Molecular basis of differences among statins and a comparison with antioxidant vitaminsR Preston MasonPageof 10